Ceramide Risk Score in the Evaluation of Metabolic Syndrome: An Additional or Substitutive Biochemical Marker in the Clinical Practice?

Ceramide risk score (CERT1, ceramide test 1), based on specific ceramides (Cers) and their corresponding ratios in the plasma, has been reported as a promising biochemical marker for primary and secondary prediction of cardiovascular disease (CVD) risk in different populations of patients. Thus far,...

Descripción completa

Detalles Bibliográficos
Autores principales: Rigamonti, Antonello E., Dei Cas, Michele, Caroli, Diana, Bondesan, Adele, Cella, Silvano G., Paroni, Rita, Sartorio, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10420317/
https://www.ncbi.nlm.nih.gov/pubmed/37569827
http://dx.doi.org/10.3390/ijms241512452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10420317/
https://www.ncbi.nlm.nih.gov/pubmed/37569827
http://dx.doi.org/10.3390/ijms241512452

Ejemplares similares